Objective:

To outline a systematic approach for developing both qualitative and quantitative methods for nitrosamine analysis.

Approach:

Key Findings:

• Current technologies can adequately quantify known nitrosamines to proposed limits, but unique approaches are required for different formulated products due to varying solubility and compatibility factors.
• Solid-phase extraction (SPE) can enhance detection limits for dilute samples, particularly in liquid formulations.

Interpretation:

The methodical approach to nitrosamine analysis emphasizes the importance of tailored strategies for different compounds and formulations, alongside rigorous validation to ensure reliability and address specific challenges.

Limitations:

• Challenges remain for certain nitrosamines and drug products, particularly those with complex matrices.
• Existing methods may not be compatible with all formulations, necessitating further method development.

Conclusion:

A systematic method development process, supported by resources from organizations like the USP, including reference materials and analytical method repositories, is crucial for robust nitrosamine detection.

Sources:

• United States Pharmacopeia (USP)
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.